Regarding IGF2BP3, all four pancreatic cancer datasets indicated overexpression in both pancreatic carcinoma and pancreatic ductal adenocarcinoma (Table 1) [12–16]. This evidence concerns the gene IGF2BP3 and pancreatic neoplasm.